Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 9129 - 9136 of 12107 results

Register For Our September Webinar -- Another Cop on the Cybersecurity Beat: What to Do Before and After the SEC and FINRA Come Knocking?

September 18, 2015| Blog| Viewpoint

Thinking Big about Data – the new EDPS Ethics Board

September 18, 2015| Blog| Viewpoint

Back to School - and the SEC Cybersecurity Exams (Register now for our September Privacy Webinar!)

September 18, 2015| Blog| Viewpoint

Legislative Roundup on Energy from the New England States

September 17, 2015| Blog| Viewpoint

NJ Appellate Court Offers New Guidance on Employee Arbitration Agreements

September 17, 2015| Blog| Viewpoint

Senators to Receive Update on Biosimilar Implementation from CDER’s Woodcock

September 17, 2015| Blog| Viewpoint

GAO Report on EB-5 a Possible Blueprint for Lawmakers and New Legislation

September 17, 2015| Blog| Viewpoint

FDA Releases Two Final Food Safety Rules: What You Need to Know

September 17, 2015| Blog| Viewpoint

News & Press Releases

SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals

August 19, 2025

Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

Mintz Advises Underwriters in Assembly Biosciences' $175 Million Underwritten Offering and Concurrent Private Placement

August 18, 2025

Mintz advised the underwriters in connection with Assembly Biosciences, Inc.’s underwritten offering of an aggregate of 5,591,840 shares of common stock and pre-funded warrants to purchase up to 1,040,820 shares of common stock, together with accompanying Class A and Class B warrants to purchase up to an aggregate of 6,632,660 shares of common stock at a combined price per share of common stock and accompanying Class A warrant and Class B warrant of $19.60 and a combined price per pre-funded warrant and accompanying Class A warrant and Class B warrant of $19.599.

View all News and Press Releases